DalsnaFinance › IPOs › Aclaris Therapeutics Inc › IPO
Aclaris Therapeutics, Inc. completed its initial public offering on NASDAQ on October 7, 2015, pricing at $11.00 a share.
| Ticker | ACRS |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | October 7, 2015 |
| Offering price | $11.00 |
| Shares offered | 5,000,000 |
| Total raised | $55M |
Aclaris Therapeutics, Inc. sold 5,000,000 shares at $11.00 each on NASDAQ. Multiplied out, that is $55 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $55 million total recorded for the deal.
Aclaris Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Aclaris Therapeutics, Inc.. This page is general information, not investment advice.